Genetic Lesions in MYC and STAT3 Drive Oncogenic Transcription Factor Overexpression in Plasmablastic Lymphoma.

Haematologica - Italy
doi 10.3324/haematol.2020.251579
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Spontaneous Regression of a Plasmablastic Lymphoma With MYC Rearrangement

British Journal of Haematology
Hematology
2019English

WS5, a Direct Target of Oncogenic Transcription Factor Myc, Is Related to Human Melanoma Glycoprotein Genes and Has Oncogenic Potential

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Genetic Reporter System for Oncogenic Igh–Myc Translocations in Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Plasmablastic Lymphoma in the Anal Canal

Cancer Research and Treatment
Cancer ResearchOncology
2009English

Co-Overexpression of BCL-2 and C-Myc in Uterine Cervix Carcinomas and Premalignant Lesions

European Journal of Histochemistry
MedicineCell BiologyHistologyBiophysics
2011English

Plasmablastic Lymphoma Mimicking Acute Pancreatitis

Case Reports in Oncological Medicine
Oncology
2016English

Oncogenic Activation of Stat3 Pathway Drives Pd-L1 Expression in Natural Killer/T Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Rectal Plasmablastic Lymphoma in HIV/AIDS: Two Cases

World Journal of Oncology
Cancer ResearchOncology
2013English

STAT3 Activation and Oncogenesis in Lymphoma

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy